British Doctors Aspirin Trial

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

The British Doctors Aspirin Trial was a randomized controlled trial started about 1980 that was designed to test chemoprevention with aspirin for the primary prevention of vascular disease.[1]

Secondary analysis of the British Doctors Aspirin Trial suggest aspirin may reduce colorectal cancer.[2]

References

  1. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K et al. (1988). "Randomised trial of prophylactic daily aspirin in British male doctors.". Br Med J (Clin Res Ed) 296 (6618): 313-6. PMID 3125882. PMC PMC2544821.
  2. Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial (2007). "Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.". Lancet 369 (9573): 1603-13. DOI:10.1016/S0140-6736(07)60747-8. PMID 17499602. Research Blogging. Review in: ACP J Club. 2007 Nov-Dec;147(3):72